Joint workshop of EpiLipidNET WG2 and Stratagem COST Action
Multidrug resistant (MDR) solid tumour research meets lipidomics and epilipidomics research. Members of two COST Actions: EpiLipidNET and Stratagem will…
Multidrug resistant (MDR) solid tumour research meets lipidomics and epilipidomics research. Members of two COST Actions: EpiLipidNET and Stratagem will…
Dear Stratagem members, we are happy to announce the last event of our fruitful action: This will be a webinar…
Dear STRATAGEM members, It is a pleasure to announce that our COST Action has been awarded with the COST Innovator…